Sanofi
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases

Last updated:

Abstract:

The present invention provides substituted pyrido[2,3-d]pyrimidine compounds useful as inhibitors of protein kinases, pharmaceutically acceptable compositions thereof, and methods of using the same.

Status:
Grant
Type:

Utility

Filling date:

28 Aug 2018

Issue date:

14 Apr 2020